These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7631488)

  • 21. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines.
    Mulcahy G; O'Connor F; Clery D; Hogan SF; Dowd AJ; Andrews SJ; Dalton JP
    Res Vet Sci; 1999 Aug; 67(1):27-33. PubMed ID: 10425237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to Schistosoma bovis in sheep induced by an experimental Fasciola hepatica infection.
    Rodríguez-Osorio M; Gómez-García V; Rojas-González J; Ramajo-Martín V; Manga-González MY; González-Lanza C
    J Parasitol; 1993 Apr; 79(2):223-5. PubMed ID: 8459332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
    Mulcahy G; Dalton JP
    Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasciola hepatica: characterization of somatic and excretory-secretory antigens of adult flukes recognized by infected sheep.
    Ruiz-Navarrete MA; Arriaga C; Bautista CR; Morilla A
    Rev Latinoam Microbiol; 1993; 35(3):301-7. PubMed ID: 8047733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a commercially available enzyme-linked immunosorbent assay for detecting antibodies to Fasciola hepatica and Fasciola gigantica in cattle, sheep and buffaloes in Australia.
    Molloy JB; Anderson GR; Fletcher TI; Landmann J; Knight BC
    Vet Parasitol; 2005 Jun; 130(3-4):207-12. PubMed ID: 15925723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The immune response of various species to Fasciola hepatica infection].
    Jedlina-Panasiuk L
    Wiad Parazytol; 2002; 48(1):11-21. PubMed ID: 16883699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with cathepsin L proteinases CL1 and CL2 secreted by Fasciola hepatica elicit a preferential type 1 response based on IgG2a antibodies in rats.
    Bentancor A; Piacenza L; Carmona C
    J Helminthol; 2002 Sep; 76(3):199-205. PubMed ID: 12363372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-course analysis of coproantigens in rats infected and challenged with Fasciola hepatica.
    Paz-Silva A; Pedreira J; Sánchez-Andrade R; Suárez JL; Díaz P; Panadero R; Díez-Baños P; Morrondo P
    Parasitol Res; 2002 Jun; 88(6):568-73. PubMed ID: 12107481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
    Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
    Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flow cytometry analysis of leukocytes response in rats immunized and infected with Fasciola hepatica].
    Jedlina-Panasiuk L
    Wiad Parazytol; 2004; 50(3):477-81. PubMed ID: 16865956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding.
    Ahmed T; Svennerholm AM; Al Tarique A; Sultana GN; Qadri F
    Vaccine; 2009 Feb; 27(9):1433-9. PubMed ID: 19146904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD.
    López-Abán J; Casanueva P; Nogal J; Arias M; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Muro A
    Vet Parasitol; 2007 Apr; 145(3-4):287-96. PubMed ID: 17275191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.
    Mooney L; Good B; Hanrahan JP; Mulcahy G; de Waal T
    Vet Parasitol; 2009 Oct; 164(2-4):201-5. PubMed ID: 19556063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms.
    Loeffler DI; Smolen K; Aplin L; Cai B; Kollmann TR
    Vaccine; 2009 Feb; 27(6):919-27. PubMed ID: 19059297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
    J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of an ivermectin/closantel injection against experimentally induced infections and field infections with gastrointestinal nematodes and liver fluke in cattle.
    Borgsteede FH; Taylor SM; Gaasenbeek CP; Couper A; Cromie L
    Vet Parasitol; 2008 Aug; 155(3-4):235-41. PubMed ID: 18562120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of vaccination of calves with recombinant cysteine proteinase of Fasciola hepatica on development and infectivity of miracidia].
    Dabrowska M; Kaliniak M; Wedrychowicz H
    Wiad Parazytol; 2006; 52(4):305-9. PubMed ID: 17432623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers.
    Laurichesse H; Gourdon F; Smits HL; Abdoe TH; Estavoyer JM; Rebika H; Pouliquen P; Catalina P; Dubray C; Beytout J
    Clin Microbiol Infect; 2007 Apr; 13(4):395-403. PubMed ID: 17359323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.